How many times should I follow up with a CEO (after a proposal)?

Wait until the review window you agreed on. If none was set, five business days. On the review date you set. If you didn't set one, five business days. After that, send a breakup note and archive it. A CEO who wants it will answer a clean close more often than a fifth bump.

Should I lower the price in the follow-up?

Not as an opening move. Ask what's blocking the decision first. If budget is the issue, trim scope or phase the work. Discounting before you know the objection trains them to wait you out. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What if they go silent after receiving the proposal?

Assume a process problem before you assume a no. Ask which layer is stuck and offer a thinner version. If you get nothing after a breakup note, archive it. Endless bumps after a proposal train them to wait for a discount.

Is it okay to send this proposal follow-up on LinkedIn instead of email?

Yes if this CEO is actually active there and the thread isn't about long attachments. Keep the LinkedIn version even shorter. Don't paste the full email. One context line and one question is plenty. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What should I never say in a Pharmaceuticals proposal follow-up?

Don't use consumer-startup slang. It's a credibility leak. A long origin story or a request to 'pick your brain.' Don't resend the PDF with 'just bumping this.' Those three mistakes show up constantly in Pharmaceuticals inboxes and they all read as "this was templated."

Pharmaceuticals · CEO · After Proposal

Proposal Follow-Up for Pharmaceuticals CEO: After Proposal

Use this proposal follow-up template when you're emailing a CEO in Pharmaceuticals (after a proposal). There's a document in play. Silence usually means a missing owner, a budget puzzle, or a comparison you can't see. Keep the note aligned with Direct, adult, light on process jargon. Talk like a peer who did the homework.

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this proposal follow-up work for a Pharmaceuticals CEO?

Name the decision owner out loud.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a CEO actually reads: Keep the whole note under 70 words unless they asked for detail.
Offer to cut scope, split phases, or walk a second stakeholder through one page.
Diagnose the stall instead of asking if they 'had a chance to review.'

When should I send this to a Pharmaceuticals CEO?

Wait until the review window you agreed on. If none was set, five business days. On the review date you set. If you didn't set one, five business days. For this combo, treat "5 business days, or the agreed date" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a CEO, Keep the whole note under 70 words unless they asked for detail.

What this CEO actually cares about

A CEO in Pharmaceuticals is protecting time, reputation, and optionality. They skim on a phone between meetings. If the first two lines don't name a business outcome, the rest never gets read. The hook that earns a look is a P&L, risk, or competitive issue they already feel. The ask should stay at this size: one decision or a 10-minute yes, not a workshop. Delete trigger: A long origin story or a request to 'pick your brain.' Tone: Direct, adult, light on process jargon. Talk like a peer who did the homework.

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Launch calendars and review boards set speed. You don't. Words that work: MLR, label, access, HCP, congress, promotional review.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone direct, adult, light on process jargon.
Don't resend the whole deck. Link the one page that matters.
Time it for 5 business days, or the agreed date. On the review date you set. If you didn't set one, five business days.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this after proposal note?

Asking 'any thoughts?' after a 12-page proposal invites silence.
Don't resend the PDF with 'just bumping this.'
Don't use consumer-startup slang. It's a credibility leak.
A long origin story or a request to 'pick your brain.'

How does this after proposal scenario compare?

Dimension	For this template
Best send window	5 business days, or the agreed date
Ideal length	Keep the whole note under 70 words unless they asked for detail.
Primary ask	one decision or a 10-minute yes, not a workshop
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Direct, adult, light on process jargon. Talk like a peer who did the homework.
Unlike after demo	The commercial conversation has started. Be explicit about decision mechanics.
Unlike invoice reminder	They don't owe you money yet. Don't sound like collections.

What should I copy and send?

Copy-ready template

Subject

[Company Name] / time through MLR

Body

Hi [First Name],

Before this sits in a pile, I can cut [option] or split the rollout.

The version of this that matters for commercial, medical, and ops leads who work under review boards and long timelines is cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. If [competitor path] is still in play, I can send a one-page comparison on [criteria they named].

Given this is after a proposal, ask whether the hold is scope, price, timing, or people.

Want a 10-minute walkthrough for whoever else needs to see it?

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Name the situation and the business object, not your excitement. Something like "[Company Name] / time through MLR" outperforms "Just checking in" because a CEO can decide from the preview text whether it's worth opening. Keep it under 50 characters when you can.

Related templates

Want a custom draft instead? Try the email generator.